10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,934,000 | +52.2% | 197,440 | +155.8% | 0.77% | +72.1% |
| Q1 2022 | $5,871,000 | -44.7% | 77,183 | +8.3% | 0.45% | -39.8% |
| Q4 2021 | $10,611,000 | +14.8% | 71,237 | +12.2% | 0.74% | +0.5% |
| Q3 2021 | $9,243,000 | -23.9% | 63,488 | +2.4% | 0.74% | -24.6% |
| Q2 2021 | $12,146,000 | +16.5% | 62,027 | +7.7% | 0.98% | +5.9% |
| Q1 2021 | $10,424,000 | – | 57,590 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |